SB 54, titled “Provides for the availability of epinephrine nasal spray in certain locations,” would amend existing Nevada laws on medication at public and private schools. Its goal is to make epinephrine nasal spray available at schools and allow trained school staff or an authorized pupil to use it for anaphylaxis (a severe allergic reaction). The bill is prefiled, not law; if enacted, it would take effect July 1, 2027.
The fiscal note says there is no effect on state or local government, but the bill gives no cost estimate for schools that choose to obtain nasal spray.
Bills on related subjects, starting with Nevada.
Public schools would require educational and athletic staff to complete six hours of suicide-prevention training before interacting with pupils; emergency plans would add annual crisis exercises with community providers.
Status
Prefiled. Referred to Committee on Education. To printer.
A bill would let trained school staff administer epinephrine for suspected anaphylaxis, even without a known allergy, and authorize transport staff to do so during travel.
Status
To Health and Human Resources
Students with severe allergies could self-administer premeasured epinephrine in schools and related activities. The bill would extend good-faith immunity to staff and broaden training to cover premeasured doses.
Status
Effective date, January 1, 2027.
A bill would require a full-time nurse in every public school and create allergy training and emergency plans.
Status
Re-ref Com On Appropriations/Base Budget